The S&P/ASX 200 Index (ASX: XJO) lifted higher on Monday, opening the trading week with a 0.83% gain up to 7,854.1 points.

ASX 200 investors are overheating their sell buttons today. But why? The post Why is the ASX 200 down so much today? appeared ...

Learn More The S&P/ASX 200 Index (ASX: XJO) once again recorded a heavy loss for this Wednesday's trading session, entering official correction territory and further exacerbating the market sell ...

The $31 billion ASX 200 stock is up 27% in 12-months and this expert says it’s now a “buying opportunity”. The post Why this ...

The S&P/ASX 200 Benchmark Index is down 158.47 points or 1.99% this week to 7789.70 --Largest four-week point decline since the week ending April 3, 2020 ...

The S&P/ASX 200 is recognized as the institutional investable benchmark in Australia. Index constituents are drawn from eligible companies listed on the ASX. The S&P/ASX 200 is designed to measure ...

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...

Shares down; Nine confirms Matt Stanton as CEO; Macquarie cuts coal forecasts; ACCC concerned by Silk deal; Boss buys ...

ASX higher; Fortescue jumps 2pc, A2 milk rallies on China stimulus hopes; RBC gloomy on lithium stocks; Myer hires ex-David ...

NEW YORK, March 06, 2025 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced its addition to the S&P ...

John MacKenzie, Capstone’s CEO, commented, “We are very pleased to have been included in the S&P/ASX 200 Index as part of the March rebalance. Inclusion in this index recognizes the continued ...